Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4+ GBM cells: A proof of principle
2022 · Molecular Therapy — Oncolytics · 16 citations
https://doi.org/10.1016/j.omto.2022.06.002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2
Papers
16
Citations
1
h-index
1
i10-index
Maxime Dubois is an academic researcher from University of Liège. The author has contributed to research in topics: Virus-based gene therapy research & Immunotherapy and Immune Responses & Cytomegalovirus and herpesvirus research. The author has an h-index of 1, co-authored 2 publications.
Click to start Chat